Drugs
20 State AGs Warn About Chinese API Suppliers for GLP-1s
A coalition of 20 state attorneys general is urging the Trump administration to tighten or suspend an FDA import program, alleging that Chinese suppliers are exploiting it to send unapproved pharmaceutical ingredients used in compounded GLP-1 products into the U.S. In a letter led by Alabama Attorney General